We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+13.26%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.72B
AUM Growth
+$105M
(+4%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-4.86%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
375
New
47
Increased
55
Reduced
135
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$87.4M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$17.9M |
| 3 |
Energy Transfer Partners
ET
|
+$16.5M |
| 4 |
Estee Lauder
EL
|
+$16.5M |
| 5 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$64.8M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$46.9M |
| 3 |
HCA Healthcare
HCA
|
+$31.8M |
| 4 |
Amazon
AMZN
|
+$24.9M |
| 5 |
PayPal
PYPL
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.09% |
| 2 | Consumer Discretionary | 17.93% |
| 3 | Healthcare | 13.09% |
| 4 | Financials | 12.38% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Under Armour Class C
UA
$2.95B
| $24K | ﹤0.01% |
1,349
| – | – |
|
327
Agilysys
AGYS
$3.21B
| – | – |
-77,086
| Closed | -$4.04M |
|
328
Allegion
ALLE
$13.5B
| – | – |
-8,485
| Closed | -$1.12M |
|
329
Apollo Global Management
APO
$69B
| – | – |
-2,125
| Closed | -$131K |
|
330
Digital Turbine
APPS
$982M
| – | – |
-47,027
| Closed | -$3.23M |
|
331
Alphatec Holdings
ATEC
$1.48B
| – | – |
-411,475
| Closed | -$5.02M |
|
|
AXON
332
Axon Enterprise
AXON
$42.8B
| – | – |
-16,980
| Closed | -$2.97M |
|
333
CareDx
CDNA
$1.83B
| – | – |
-71,720
| Closed | -$4.54M |
|
334
Church & Dwight Co
CHD
$23.7B
| – | – |
-1,825
| Closed | -$151K |
|
335
Chegg
CHGG
$116M
| – | – |
-2,155
| Closed | -$147K |
|
336
Cerence
CRNC
$359M
| – | – |
-103,046
| Closed | -$9.9M |
|
337
Castle Biosciences
CSTL
$742M
| – | – |
-147,867
| Closed | -$9.83M |
|
338
Commault Systems
CVLT
$4.98B
| – | – |
-133,375
| Closed | -$10M |
|
339
Denali Therapeutics
DNLI
$3.79B
| – | – |
-66,145
| Closed | -$3.34M |
|
340
Euronet Worldwide
EEFT
$3.19B
| – | – |
-35,221
| Closed | -$4.48M |
|
341
Enovis
ENOV
$1.74B
| – | – |
-68,708
| Closed | -$5.43M |
|
342
iShare MSCI Eurozone ETF
EZU
$9.38B
| – | – |
-309,000
| Closed | -$14.9M |
|
343
Fate Therapeutics
FATE
$275M
| – | – |
-52,908
| Closed | -$3.14M |
|
344
Globus Medical
GMED
$11.1B
| – | – |
-18,590
| Closed | -$1.42M |
|
345
Halozyme
HALO
$9.88B
| – | – |
-219,787
| Closed | -$8.94M |
|
|
346
HCA Healthcare
HCA
$90.6B
| – | – |
-130,885
| Closed | -$31.8M |
|
347
HubSpot
HUBS
$12.9B
| – | – |
-2,045
| Closed | -$1.38M |
|
348
Incyte
INCY
$25.4B
| – | – |
-1,660
| Closed | -$114K |
|
349
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
| – | – |
-66,948
| Closed | -$4.54M |
|
350
ManpowerGroup
MAN
$2.6B
| – | – |
-28,500
| Closed | -$3.09M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q4 2021 Portfolio in Review
As of Q4 2021, Castleark Management held 375 positions worth $2.72B, up 4% from $2.62B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Castleark Management withdrew a net $132M in Q4 2021, closing 49 positions and reducing 135 holdings. Its most notable exit was HCA Healthcare, an estimated $31.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Castleark Management opened a new position in iShares MSCI ACWI ex US ETF worth $15.2M.
- Castleark Management's largest Q4 2021 buy was iShares MSCI ACWI ex US ETF: 274,000 shares worth $15.2M.
- Castleark Management added most to Alphabet (Google) Class A in Q4 2021, an estimated $87.4M increase.
- Castleark Management's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $64.8M.
- Castleark Management fully exited HCA Healthcare in Q4 2021, selling an estimated $31.8M.
- Castleark Management's ten largest holdings make up 30% of its $2.72B portfolio in Q4 2021.
- Castleark Management opened 47 new positions and closed 49 in Q4 2021.
- Castleark Management's portfolio value rose 4% quarter-over-quarter to $2.72B.
Based on Castleark Management's 13F filing for Q4 2021, filed 16 Feb 2022.